1. Home
  2. TLX vs MTN Comparison

TLX vs MTN Comparison

Compare TLX & MTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLX
  • MTN
  • Stock Information
  • Founded
  • TLX 2015
  • MTN 1997
  • Country
  • TLX Australia
  • MTN United States
  • Employees
  • TLX N/A
  • MTN N/A
  • Industry
  • TLX Biotechnology: Pharmaceutical Preparations
  • MTN Services-Misc. Amusement & Recreation
  • Sector
  • TLX Health Care
  • MTN Consumer Discretionary
  • Exchange
  • TLX Nasdaq
  • MTN Nasdaq
  • Market Cap
  • TLX 5.7B
  • MTN 5.2B
  • IPO Year
  • TLX N/A
  • MTN 1997
  • Fundamental
  • Price
  • TLX $16.99
  • MTN $160.22
  • Analyst Decision
  • TLX Strong Buy
  • MTN Hold
  • Analyst Count
  • TLX 1
  • MTN 10
  • Target Price
  • TLX $22.00
  • MTN $191.50
  • AVG Volume (30 Days)
  • TLX 20.6K
  • MTN 674.1K
  • Earning Date
  • TLX 01-01-0001
  • MTN 06-05-2025
  • Dividend Yield
  • TLX N/A
  • MTN 5.54%
  • EPS Growth
  • TLX 798.14
  • MTN 10.73
  • EPS
  • TLX 0.09
  • MTN 6.89
  • Revenue
  • TLX $484,687,790.00
  • MTN $2,946,168,000.00
  • Revenue This Year
  • TLX N/A
  • MTN $4.53
  • Revenue Next Year
  • TLX N/A
  • MTN $4.18
  • P/E Ratio
  • TLX $183.81
  • MTN $23.25
  • Revenue Growth
  • TLX 55.85
  • MTN 3.57
  • 52 Week Low
  • TLX $13.61
  • MTN $129.85
  • 52 Week High
  • TLX $30.36
  • MTN $199.45
  • Technical
  • Relative Strength Index (RSI)
  • TLX N/A
  • MTN 63.30
  • Support Level
  • TLX N/A
  • MTN $144.91
  • Resistance Level
  • TLX N/A
  • MTN $175.51
  • Average True Range (ATR)
  • TLX 0.00
  • MTN 3.92
  • MACD
  • TLX 0.00
  • MTN 1.74
  • Stochastic Oscillator
  • TLX 0.00
  • MTN 50.03

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

About MTN Vail Resorts Inc.

Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.

Share on Social Networks: